A randomised open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC - the ETOP and EORTC SPLENDOUR trial
| Image |  |
|---|---|
| Description | scientific article published on 18 June 2020 |
| Author/s |
author: Manuela Rabaglio Alessandra Curioni-Fontecedro Oliver P Gautschi |
| Publication date | June 18, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |